Statistical controversies in clinical research: data access and sharing-can we be more transparent about clinical research? Let's do what's right for patients.

Journal Article (Journal Article)

Calls for greater transparency and 'open data access' in clinical research are widespread, from sources including the Executive Office of the President, which in 2013 called for increased access to the results of federally funded research. In 2015, The Institute of Medicine issued a report advocating for a multi-stakeholder effort to foster responsible data sharing, and there are many others. Open science is good for researchers, good for innovation, and good for patients. The question at the center of the open-science efforts for clinical trials should not be whether data should be shared, but rather how we can usher in responsible methods for doing so. Unfortunately, there remain numerous perceived barriers to complete transparency around clinical trial data. This paper reviews the current status of data disclosure, the barriers to achieving it and a suggestion for the future.

Full Text

Duke Authors

Cited Authors

  • Rockhold, FW

Published Date

  • August 1, 2017

Published In

Volume / Issue

  • 28 / 8

Start / End Page

  • 1734 - 1737

PubMed ID

  • 28383637

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdx123


  • eng

Conference Location

  • England